Notable companies
The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Unitedhealth Group (NYSE:UNH), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), ABBVIE (NYSE:ABBV), Abbott Laboratories (NYSE:ABT), Pfizer (NYSE:PFE), Amgen (NASDAQ:AMGN), Intuitive Surgical (NASDAQ:ISRG), Elevance Health (NYSE:ELV).
Industry description
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index.
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Market Cap
The average market capitalization across the The Health Care Select Sector SPDR® ETF ETF is 89.14B. The market cap for tickers in the group ranges from 9.7B to 739.66B. LLY holds the highest valuation in this group at 739.66B. The lowest valued company is HSIC at 9.7B.
High and low price notable news
The average weekly price growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 4%. For the same ETF, the average monthly price growth was 14%, and the average quarterly price growth was 43%. ILMN experienced the highest price growth at 6%, while CVS experienced the biggest fall at -7%.
Volume
The average weekly volume growth across all stocks in the The Health Care Select Sector SPDR® ETF ETF was 1%. For the same stocks of the ETF, the average monthly volume growth was -18% and the average quarterly volume growth was 13%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 51
P/E Growth Rating: 60
Price Growth Rating: 51
SMR Rating: 61
Profit Risk Rating: 55
Seasonality Score: 17 (-100 ... +100)